trending Market Intelligence /marketintelligence/en/news-insights/trending/td9jy9sZeJpyWR2ASXrpcw2 content esgSubNav
In This List

Bellicum Pharmaceuticals appoints chief business officer

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Bellicum Pharmaceuticals appoints chief business officer

Gregory Naeve will become Bellicum Pharmaceuticals Inc.'s chief business officer Aug. 21.

Naeve was previously immuno-oncology and cell therapy lead for Pfizer Inc.'s external research and development unit.